Year archive

EXACT Therapeutics AS — 2025 filings

All 26 regulatory filings released by EXACT Therapeutics AS (EXTX) in 2025, sourced directly from the official regulator.

26 Filings

2025 Period

2025 filings (26)

Filing	Released	Lang
EXACT Therapeutics to present company update - Attachment: 251125 Exact Therapeutics - DNB Healthcare conf - non-conf.pdf Investor Presentation	2025-11-25	English
EXACT Therapeutics to present company update Report Publication Announcement	2025-11-25	English
EXACT Therapeutics AS: New option program and receipt of share options by primary insiders - Attachment: EXTX PDMR attachments to stock announcement.pdf Director's Dealing	2025-11-24	English
EXACT Therapeutics AS: New option program and receipt of share options by primary insiders Remuneration Information	2025-11-24	English
EXACT Therapeutics first half 2025 interim results - Attachment: EXACT Therapeutics 1H 2025 Financial report.pdf Interim / Quarterly Report H1 2025	2025-09-25	English
EXACT Therapeutics first half 2025 interim results Report Publication Announcement	2025-09-25	English
EXACT Therapeutics’ Phase 2 trial to be presented at the 2025 AACR Special Conference Regulatory Filings	2025-09-18	English
EXACT Therapeutic’s Acoustic Cluster Therapy to be presented at the Ninth International Cancer lmmunotherapy Conference Regulatory Filings	2025-09-09	English
EXACT Therapeutics to Present at the European Society for Medical Oncology (ESMO) Congress 2025 Regulatory Filings	2025-08-12	English
Financial calendar Report Publication Announcement	2025-08-11	English
EXACT Therapeutics announces grant of core patent in the U.S. Regulatory Filings	2025-07-08	English
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer Regulatory Filings	2025-06-24	English
EXACT Therapeutics AS: Primary insider notification - Attachment: Notification of transactions by Primary Insiders (grant options).pdf Director's Dealing	2025-06-13	English
EXACT Therapeutics AS: Primary insider notification Board/Management Information	2025-06-13	English
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 - Attachment: 20250613_EXACT_Therapeutics_AS_AGM.pdf AGM Information	2025-06-13	Norwegian
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 AGM Information	2025-06-13	English
EXACT Therapeutics AS – Information regarding voting at the Annual General Meeting 2025 AGM Information	2025-06-04	English
EXACT Therapeutics AS - Notice of Annual General Meeting 2025 - Attachment: AGM Notice - EXACT Therapeutics AS 13 June 2025.pdf AGM Information	2025-05-28	Norwegian
EXACT Therapeutics AS - Notice of Annual General Meeting 2025 AGM Information	2025-05-28	English
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer Earnings Release FY 2025	2025-05-20	English
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer Earnings Release Q2 2025	2025-05-20	English
EXACT Therapeutics announces grant of key patent covering non-invasive delivery of pharmaceuticals to the brain Regulatory Filings	2025-05-14	English
EXACT Therapeutics announces grant of key patent in Japan Regulatory Filings	2025-05-07	English
EXACT Therapeutics - 2024 Annual Report Annual Report FY 2024	2025-04-09	English
EXACT Therapeutics - 2024 Annual Report Report Publication Announcement	2025-04-09	English
EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brain Cancer Mice Model Regulatory Filings	2025-01-28	English